Trial Profile

A Multi-Center, Open-Label, Phase 2 Trial to Evaluate the Efficacy and Safety of CartiLife® for Patients With Articular Cartilage Defects in the Knee

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 27 May 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Autologous chondrocyte implantation-Biosolutions (Primary)
Indications Cartilage disorders; Meniscus disorders
Focus Therapeutic Use
Sponsors Biosolution

Most Recent Events

18 May 2022 Trial design changed from parallel assignment to single group assignment. Microfracture surgery that is active comparator arm discontinued from the trial.
18 May 2022 Planned number of patients changed from 50 to 25.
18 May 2022 Planned primary completion date changed from 1 Dec 2022 to 1 Dec 2023.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com